Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study.
Saved in:
| Title: | Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study. |
|---|---|
| Authors: | Qian S; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Xu D; Department of Pharmacy, Nanjing Drum Tower Hospital, China Pharmaceutical University, Nanjing, China., Xu Y; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Qi H; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Liang P; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 May 29; Vol. 17, pp. 1833093. Date of Electronic Publication: 2026 May 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42292850 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Qian+S%22">Qian S</searchLink>; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Xu+D%22">Xu D</searchLink>; Department of Pharmacy, Nanjing Drum Tower Hospital, China Pharmaceutical University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Qi+H%22">Qi H</searchLink>; Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Liang+P%22">Liang P</searchLink>; Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 May 29; Vol. 17, pp. 1833093. <i>Date of Electronic Publication: </i>2026 May 29 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42292850 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2026.1833093 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1833093 Titles: – TitleFull: Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Qian S – PersonEntity: Name: NameFull: Xu D – PersonEntity: Name: NameFull: Xu Y – PersonEntity: Name: NameFull: Qi H – PersonEntity: Name: NameFull: Liang P IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 05 Text: 2026 May 29 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |